Compare
IP Strategy Holdings, Inc. vs Buda Juice, Inc. vs Arcadia Biosciences, Inc. vs Jones Soda Co.
| Latest fiscal year | IP Strategy Holdings, Inc. IPST | Buda Juice, Inc. BUDA | Arcadia Biosciences, Inc. RKDA | Jones Soda Co. JSDA |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $10.12M | $12.61M | $4.86M | $25.30M |
| Revenue growth (YoY) | +20.4% | +11.8% | -3.7% | +42.2% |
| Gross margin | 54.9% | 44.6% | 36.2% (computed) | 26.7% |
| Operating margin | n/m | 27.4% | -51.5% | -18.8% |
| Net margin | n/m | 28.0% | -48.1% | -7.0% |
| Net income | -$137.72M | $3.53M | -$2.34M | -$1.78M |
| EPS (Diluted) | -$16.03 | $0.20 | -$1.71 | -$0.01 |
| Operating cash flow | -$15.33M | $3.15M | -$4.74M | -$1.26M |
| Free cash flow | -$15.40M | $2.90M | -$4.74M | -$1.72M |
| Cash & equivalents | n/a | n/a | $259.0K | $3.60M |
| Total assets | $108.76M | $4.97M | $6.55M | $15.23M |
| Total liabilities | $10.54M | $1.23M | $2.41M | $13.76M |
| Shareholders' equity | $98.22M | $3.74M | $4.14M | $1.47M |
| Return on year-end equity | -140.2% | 94.5% | -56.5% | -121.4% |
| Shares outstanding | 9.65M | n/a | 1.37M | 118.23M |
Revenue, most recent five fiscal years
| Fiscal year | IP Strategy Holdings, Inc. | Buda Juice, Inc. | Arcadia Biosciences, Inc. | Jones Soda Co. |
|---|---|---|---|---|
| Latest | $10.12M Ended 2025-12-31 | $12.61M Ended 2025-12-31 | $4.86M Ended 2025-12-31 | $25.30M Ended 2025-12-31 |
| 1 year earlier | $8.40M Ended 2024-12-31 | $11.27M Ended 2024-12-31 | $5.04M Ended 2024-12-31 | $17.79M Ended 2024-12-31 |
| 2 years earlier | $7.97M Ended 2023-12-31 | n/a | $4.45M Ended 2023-12-31 | $16.67M Ended 2023-12-31 |
| 3 years earlier | n/a | n/a | $7.42M Ended 2022-12-31 | $19.09M Ended 2022-12-31 |
| 4 years earlier | n/a | n/a | $6.78M Ended 2021-12-31 | $14.79M Ended 2021-12-31 |